Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology.
Gohlke-Bärwolf
C
C
Kreutz Rehabilitationszentrum für Herz und Kreislaufkranke, Krozingen, FRG.
Acar
J
J
Burckhardt
D
D
Oakley
C
C
Butchart
E
E
Krayenbühl
P
P
Hall
R
R
Bodnar
E
E
Krzeminska-Pakula
M
M
Delahaye
J P
JP
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001705:Bioprosthesis; D005260:Female; D006349:Heart Valve Diseases / Q000097:blood / Q000401:mortality / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D008134:Long-Term Care; D011183:Postoperative Complications / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D011247:Pregnancy; D011474:Prosthesis Design; D012307:Risk Factors; D015996:Survival Rate; D013923:Thromboembolism / Q000097:blood / Q000401:mortality / Q000517:prevention & control*
D000925:Anticoagulants